SYRE
Spyre Therapeutics Inc.
$15.29
+$0.41(+2.76%)
50
Overall
--
Value
50
Tech
--
Quality
Market Cap
$898.77M
Volume
608.14K
52W Range
$10.91 - $40.26
Target Price
$53.90
Key Metrics Overview
| Market Cap | $898.77M | P/E Ratio | N/A |
| 52W High | $40.26 | 52W Low | $10.91 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 0.0% | 52W Position | 14.9% |
| Overall Score | 50 | Value Score | -- |
| Quality Score | -- | Technical Score | 50 |
Growth Analysis
| EPS Current Est | $-2.87 | EPS Next Est | $-3.14 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SYRE | $15.29 | +2.8% | 608.14K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |